At TrimRx, our mission is to help you embrace a healthier lifestyle through science and empathy
Disclosures: Daljeet Chahal: Nothing to Disclose, Donald Griesdale: Nothing to Disclose, Laura Hornby: Nothing to Disclose, Jordan Bird: Kent Imaging Inc.: Consultant, Mypinder Sekhon: Nothing to Disclose 1298 ANALYSIS OF THE IMPACT OF FEMALE SEX AND SARCOPENIA ON SERUM CREATININE AND WAITLIST PRIORITY FOR LIVER TRANSPLANTATION Shivangi Gupta 1 Angus Jeffrey 2 Zhengyi Wang 3 Leon Adams 4 George Garas 4 Gerry MacQuillan 4 Michael Wallace 2 Briohny Smith 2 Wai Lim 4 Ros Francis 4 Christopher Welman 5 Gary Jeffrey 4 , 1 Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia, 2 Sir Charles Gairdner Hospital, 3 University of Western Australia, Perth, 4 Sir Charles Gairdner Hospital, WA, Aus, 5 Fiona Stanley Hospital, Perth, WA, Aus Background: Model for End-Stage Liver Disease (MELD) score incorporates sCr, which is a poor measure of renal function in cirrhotic patients
![glp-1 versus ozempic How Keto Does What Promises [Keto vs. Ozempic] GLP-1 Agonists for Weight Loss:](https://images.everydayhealth.com/images/seo-graphic-content-initiative/eh-how-medical-weight-loss-methods-compare-seo-graphics-(1)-(1).png?sfvrsn=c236e848_3)
Drug compounding is allowed when drugs are on the FDA's shortage list, or in circumstances when a patient can't take a version of a drug made by a pharmaceutical company and they need an alternative
Key Timeline Dates: August 2, 2023: First lawsuit filed by Jaclyn Bjorklund February 2024: MDL 3094 created, cases consolidated July 3, 2024: Mass Eye & Ear NAION study published December 2024: 1,300 pending cases January 2026: 3,063 pending cases (more than doubled) May 14, 2025: Critical hearing scheduled on admissibility of expert causation testimony Settlement Projections (Not Actual Payouts) Attorney Estimates No Settlements Finalized Important Disclaimer: No global settlements have been announced as of January 2026
When symptoms continue despite these steps, doctors start looking for different strategies